BANGALORE, April 4, 2017 /PRNewswire/ --
Vascular Concepts Ltd, a leading organization in cardiovascular technology, received the renowned '2017 Asia-Pacific Coronary Care-Drug Eluting Stent Growth Excellence Leadership Award' on 14 March, 2017 in London, United Kingdom. Frost & Sullivan presents this award in recognition of companies that push the boundaries of excellence and demonstrate an outstanding performance in the Asia-Pacific market in cardiac care, by developing innovative strategies to deliver growth beyond drug eluting stents. This honor also highlights excellence in promoting products that primarily focus on patients' safety and performance. It validates the company's successful use of a 'quality-focused approach' to product manufacturing in Germany, which ensures product integrity at the highest level as well as continuous focus on a 'patient-centric approach' to treating cardiovascular diseases (CVD). This recognition also acknowledges the company's continuous focus on developing technologically innovative products. Hence, Vascular Concepts demonstrates superior growth excellence as a leading organization dedicated to offering consumers affordable products from its competitive, broad, and visionary product portfolio.
Innovation and smart technologies are essential to providing solutions that address the rising risks of CVDs, as demonstrated through Vascular Concepts' wide range of products. The company continues to innovate in the field of structural heart, coronary, and peripheral vascular diseases. Over 500,000 coronary stents and 25,000 congenital heart defect devices have been implanted by the company till date. The cardiac stents have undergone continuous evolution from the basic bare metal stents (BMS) to the advanced drug eluting stents (DES) of today. Further, Vascular Concepts pioneered the extra-long stents now used in the drug eluting category. Its upcoming aortic valve (transcatheter aortic valve implant) product is another revolutionary solution in the field of angioplasty, and is now undergoing clinical studies.
Vascular Concepts' 'Heart Insure Program' is a patient-welfare campaign that offers patients post-procedure health guidance and lifestyle management tips provided through regular follow up phone calls by a dedicated team. In addition, the company conducts periodic patient awareness camps where the treated patients undergo basic cardiac investigations and consultations from their cardiologists. The patient-centric approach of this novel disease management program has motivated cardiologists to join and recommend the beneficial service by Vascular Concepts to their patients as a pro-active way to promote wellness.
Vascular Concepts previously won the prestigious Alexandria-Frost & Sullivan Award for Excellence in Indian Healthcare, under the 'Indian Medical Devices Company of The Year' in 2010 and 2011. It is the only Indian company with an extensive patent portfolio exceeding 35 US/EU technology patents. Many of these patents cover the design and manufacturing of various peripheral vascular products to treat diseases apart from those associated with the heart. Additionally, all certifications are granted by BSI (British Standards Certifications), one of the best-recognized notified bodies in the world. Moreover, Germany is used as a base for manufacturing to ensure tight quality control of the products the company's valued patients will receive.
With the recent drop in medical devices prices and the government's initiative to control costs, 2017 marks a seminal moment in India's healthcare landscape as the medical device industry becomes more competitive and coalesces new goals that will determine innovative solutions for treating CVD. Vascular Concepts is proud to have a role in accelerating progress towards making Indian healthcare more affordable, effective, and equitable for the significantly-sized underserved population.
"Whilst we understand that there are many aspects to a business' success, corporate leaders are at the forefront of medical device industry development, utilizing their ingenuity, creativity, and experience to steer their firm through trying economic times, competitively pricing their products, and developing strategies to attract and retain customers. Overcoming adversity is the key to good business leadership, and this award is an incredible achievement for our company that is working relentlessly to help the business, as well as the wider industry, prosper, despite operating in an increasingly tough climate," said Chairman and Managing Director Swaminathan Jayaraman, Vascular Concepts Ltd.
Swaminathan Jayaraman further commented, "Sustainable development begins with promoting a safe and healthy country. We are entering a significant phase where efforts to prioritize investments in innovation and research are being initiated that can deliver better health and value for money to our patients. We aim to create financially sustainable results that can reach the masses, which have yet to share the gains of our progress. The award is also a testament to the skill, vision, and shared aspirations of our team."
Award link: https://ww2.frost.com/event/calendar/2017-best-practices-awards-banquet-london/
About Vascular Concepts:
Vascular Concepts is a 150 crore Indian company which serves as a global leader in cardiovascular technology. Founded in 1998, it has its corporate headquarters & R&D facility is based in Bangalore.
Vascular Concepts designs, develops, manufactures and markets endovascular devices that aid less invasive therapy. It offers its products for the treatment of arterial diseases, which include coronary artery and peripheral vascular diseases.
For media queries: Bhakti Dalal: +91-9819118807 [email protected]
Advertisement
Vascular Concepts Ltd, a leading organization in cardiovascular technology, received the renowned '2017 Asia-Pacific Coronary Care-Drug Eluting Stent Growth Excellence Leadership Award' on 14 March, 2017 in London, United Kingdom. Frost & Sullivan presents this award in recognition of companies that push the boundaries of excellence and demonstrate an outstanding performance in the Asia-Pacific market in cardiac care, by developing innovative strategies to deliver growth beyond drug eluting stents. This honor also highlights excellence in promoting products that primarily focus on patients' safety and performance. It validates the company's successful use of a 'quality-focused approach' to product manufacturing in Germany, which ensures product integrity at the highest level as well as continuous focus on a 'patient-centric approach' to treating cardiovascular diseases (CVD). This recognition also acknowledges the company's continuous focus on developing technologically innovative products. Hence, Vascular Concepts demonstrates superior growth excellence as a leading organization dedicated to offering consumers affordable products from its competitive, broad, and visionary product portfolio.
Advertisement
Innovation and smart technologies are essential to providing solutions that address the rising risks of CVDs, as demonstrated through Vascular Concepts' wide range of products. The company continues to innovate in the field of structural heart, coronary, and peripheral vascular diseases. Over 500,000 coronary stents and 25,000 congenital heart defect devices have been implanted by the company till date. The cardiac stents have undergone continuous evolution from the basic bare metal stents (BMS) to the advanced drug eluting stents (DES) of today. Further, Vascular Concepts pioneered the extra-long stents now used in the drug eluting category. Its upcoming aortic valve (transcatheter aortic valve implant) product is another revolutionary solution in the field of angioplasty, and is now undergoing clinical studies.
Vascular Concepts' 'Heart Insure Program' is a patient-welfare campaign that offers patients post-procedure health guidance and lifestyle management tips provided through regular follow up phone calls by a dedicated team. In addition, the company conducts periodic patient awareness camps where the treated patients undergo basic cardiac investigations and consultations from their cardiologists. The patient-centric approach of this novel disease management program has motivated cardiologists to join and recommend the beneficial service by Vascular Concepts to their patients as a pro-active way to promote wellness.
Vascular Concepts previously won the prestigious Alexandria-Frost & Sullivan Award for Excellence in Indian Healthcare, under the 'Indian Medical Devices Company of The Year' in 2010 and 2011. It is the only Indian company with an extensive patent portfolio exceeding 35 US/EU technology patents. Many of these patents cover the design and manufacturing of various peripheral vascular products to treat diseases apart from those associated with the heart. Additionally, all certifications are granted by BSI (British Standards Certifications), one of the best-recognized notified bodies in the world. Moreover, Germany is used as a base for manufacturing to ensure tight quality control of the products the company's valued patients will receive.
With the recent drop in medical devices prices and the government's initiative to control costs, 2017 marks a seminal moment in India's healthcare landscape as the medical device industry becomes more competitive and coalesces new goals that will determine innovative solutions for treating CVD. Vascular Concepts is proud to have a role in accelerating progress towards making Indian healthcare more affordable, effective, and equitable for the significantly-sized underserved population.
"Whilst we understand that there are many aspects to a business' success, corporate leaders are at the forefront of medical device industry development, utilizing their ingenuity, creativity, and experience to steer their firm through trying economic times, competitively pricing their products, and developing strategies to attract and retain customers. Overcoming adversity is the key to good business leadership, and this award is an incredible achievement for our company that is working relentlessly to help the business, as well as the wider industry, prosper, despite operating in an increasingly tough climate," said Chairman and Managing Director Swaminathan Jayaraman, Vascular Concepts Ltd.
Swaminathan Jayaraman further commented, "Sustainable development begins with promoting a safe and healthy country. We are entering a significant phase where efforts to prioritize investments in innovation and research are being initiated that can deliver better health and value for money to our patients. We aim to create financially sustainable results that can reach the masses, which have yet to share the gains of our progress. The award is also a testament to the skill, vision, and shared aspirations of our team."
Award link: https://ww2.frost.com/event/calendar/2017-best-practices-awards-banquet-london/
About Vascular Concepts:
Vascular Concepts is a 150 crore Indian company which serves as a global leader in cardiovascular technology. Founded in 1998, it has its corporate headquarters & R&D facility is based in Bangalore.
Vascular Concepts designs, develops, manufactures and markets endovascular devices that aid less invasive therapy. It offers its products for the treatment of arterial diseases, which include coronary artery and peripheral vascular diseases.
For media queries: Bhakti Dalal: +91-9819118807 [email protected]
